4D Molecular Therapeutics Ownership | Who Owns 4D Molecular Therapeutics?
4D Molecular Therapeutics Ownership Summary
4D Molecular Therapeutics is owned by 84.35% institutional investors, 4.16% insiders, and 11.49% retail investors. Blackrock is the largest institutional shareholder, holding 9.94% of FDMT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.32% of its assets in 4D Molecular Therapeutics shares.
FDMT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | 4D Molecular Therapeutics | 84.35% | 4.16% | 11.49% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 4.90M | 9.94% | $102.79M |
| Blackrock funding, inc. /de | 4.92M | 8.86% | $27.41M |
| Ra capital management | 4.56M | 8.21% | $25.42M |
| Goldman sachs group | 4.27M | 7.70% | $23.81M |
| Vr adviser | 2.95M | 5.31% | $16.44M |
| Vanguard group | 2.86M | 5.15% | $15.93M |
| Bvf inc/il | 2.67M | 4.81% | $14.88M |
| Janus henderson group | 2.25M | 4.05% | $12.54M |
| Morgan stanley | 1.46M | 2.96% | $30.65M |
| Novo | 1.50M | 2.70% | $8.36M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vr adviser | 2.95M | 1.13% | $16.44M |
| Novo | 1.50M | 0.51% | $8.36M |
| Bvf inc/il | 2.67M | 0.50% | $14.88M |
| Decheng capital | 400.00K | 0.48% | $2.23M |
| Redmile group | 1.20M | 0.46% | $6.67M |
| Casdin capital | 1.15M | 0.43% | $6.41M |
| Ra capital management | 4.56M | 0.34% | $25.42M |
| Braidwell lp | 1.23M | 0.20% | $6.83M |
| Privium fund management b.v. | 121.00K | 0.15% | $673.97K |
| Entrypoint capital | 55.54K | 0.13% | $309.35K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 1.42M | 0.00% | 1.34M |
| Goldman sachs group | 4.27M | 0.00% | 683.94K |
| Blackrock | 4.90M | 0.00% | 612.35K |
| Jpmorgan chase | 820.07K | 0.00% | 504.09K |
| Norges bank | 500.82K | 0.00% | 500.82K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bvf inc/il | 2.67M | 0.50% | -4.71M |
| Deep track capital, lp | 609.90K | 0.13% | -3.49M |
| Viking global investors lp | - | - | -2.93M |
| Vr adviser | 2.95M | 1.13% | -1.45M |
| State street | 1.11M | 0.00% | -1.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 500.82K | 0.00% | 500.82K | $2.79M |
| Hudson bay capital management lp | 113.30K | 0.01% | 113.30K | $2.38M |
| Raymond james financial | 112.90K | 0.00% | 112.90K | $628.88K |
| Bnp paribas arbitrage, snc | 95.42K | 0.00% | 95.42K | $531.51K |
| Hrt financial lp | 83.42K | 0.00% | 83.42K | $464.00K |
Sold Out
| Holder | Change |
|---|---|
| Innealta capital | -4.00 |
| Nelson, van denburg & campbell wealth management group | -8.00 |
| Allspring global investments | -27.00 |
| Allworth financial lp | -28.00 |
| Rothschild investment | -35.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 144 | 2.86% | 46,861,479 | -18.79% | 84 | 0.78% | 82 | 9.33% | 44 | 2.33% |
| Sep 30, 2024 | 140 | -4.11% | 57,700,838 | 0.63% | 103 | 0.77% | 76 | -7.32% | 42 | 10.53% |
| Jun 30, 2024 | 146 | -6.41% | 57,338,955 | 1.87% | 116 | 0.89% | 82 | -21.15% | 38 | 2.70% |
| Mar 31, 2024 | 156 | 33.33% | 56,284,675 | 32.64% | 114 | 0.97% | 104 | 62.50% | 37 | 32.14% |
| Dec 31, 2023 | 117 | 1.74% | 42,433,938 | 1.23% | 108 | 1.10% | 64 | 1.59% | 28 | -15.15% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.54M | 3.32% | - |
| Vanguard US Total Market Shares ETF | 1.54M | 3.32% | - |
| iShares Russell 2000 ETF | 1.23M | 2.65% | -10.62K |
| SPDR® S&P Biotech ETF | 986.40K | 2.13% | 14.03K |
| Janus Henderson Global Life Sciences | 902.96K | 1.95% | -113.28K |
| Janus Henderson Global Life Sciences D | 887.81K | 1.92% | -15.15K |
| Janus Global Life Science AUSD | 745.08K | 1.61% | -5.82K |
| Janus Henderson Glb Life Scn I2 USD | 740.19K | 1.60% | -1.63K |
| Polar Capital Healthcare Opports Inc | 790.16K | 1.52% | - |
| Fidelity Small Cap Index | 502.68K | 1.09% | -9.41K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 16, 2024 | Bizily Scott | Chief Legal Officer | Sell | $8.16K |
| Aug 19, 2024 | Bizily Scott | Chief Legal Officer | Sell | $7.50K |
| Jul 16, 2024 | Bizily Scott | Chief Legal Officer | Sell | $47.44K |
| Jul 11, 2024 | Bizily Scott | Chief Legal Officer | Sell | $49.90K |
| Jul 10, 2024 | Kirn David | Chief Executive Officer | Sell | $290.60K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q3 | - | 6 |
| 2024 Q2 | - | 6 |
| 2024 Q1 | - | 13 |
| 2023 Q4 | - | 2 |
FDMT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools